QI
SIOX

QS Investors’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

QS Investors’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$222K Buy
+81,300
New +$202K ﹤0.01% 1035

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

QS Investors's SIOX Position: Q2 2021 in Review

QS Investors opened a new position in Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2021: 81,300 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #1035 among its holdings.

54 funds tracked by Wall St. Rank hold SIOX as of Q2 2021.

  • QS Investors held 81,300 shares of Sio Gene Therapies Inc. Common Stock worth $222K as of Q2 2021.
  • Sio Gene Therapies Inc. Common Stock was a new QS Investors position in Q2 2021.
  • Sio Gene Therapies Inc. Common Stock made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #1035 holding.
  • 54 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.